Skip to content

Oncolo-Co

Active Private limited companyfounded 2022active for 4 yearsBesmelaan 103, 1190 ForestKBO/BCE: BE 0780.358.961

Annual accounts 2025

micro format, filed on 16-10-2026, 77 days late
€190,929
▲ 10.7%
€59,086
▲ 14.5%
€175,242
▲ 3.3%
€118,168
▼ 0.8%
0.5%
▲ 0.8 percentage points
0.85
▲ 0.31

Money flows

no detail for 2025

Balance sheet

balance sheet total €1.6m on 31-12-2025
What the company ownsHow it is paid for

in euro

in euro

Position in the sector

0.5%

Lower than 95% of 21,334 companies in 2025.

0.85

Higher than 13% of 20,884 companies in 2025.

0.1%

Higher than 9% of 21,184 companies in 2025.

Oncolo-Co Middle half of the sector 80% of the sector Micro accounts in human health (NACE 86)

Net result: bottom quarter · Equity: bottom quarter · Balance sheet total: top quarter · Working capital: bottom quarter

Filed annual accounts

as filed with the National Bank, click a year to choose it
Line Trend2025202420232022
Balance sheet: assets
20/58 1.6m1.6m1.6m44,647
21/28 1.4m1.5m1.5m42,585
21 68,91997,767126,615-
22/27 1.3m1.4m1.4m42,585
22 1.1m1.2m1.2m-
23 1,1305231,4412,359
24 125,617212,255224,06940,226
26 50,93850,938--
28 75,000---
29/58 113,72035,35934,7722,062
40/41 29,7513,07017,700963
40 2,3953,07017,694910
41 27,3560653
50/53 3,500---
54/58 77,76831,04417,0721,099
490/1 2,7011,244--
Balance sheet: equity and liabilities
10/49 1.6m1.6m1.6m44,647
10/15 7,616-4,395-5,53417,583
10/11 12,5002,5002,5002,500
14 -4,884-6,895-8,03415,083
16 507,000507,000515,667-
160/5 507,000507,000515,667-
160 507,000507,000--
164/5 --515,667-
17/49 1.0m1.1m1.1m27,064
17 908,735986,031990,1256,105
170/4 908,735986,031990,1256,105
42/48 134,53765,88678,85320,960
42 64,66054,83642,989-
43 10,190---
430/8 10,190---
44 8037,63715,8225,802
440/4 8037,63715,8225,802
46 --0720
45 4,5383,4138,5179,749
450/3 4,5383,4138,5179,749
47/48 54,346011,5254,689
492/3 2,739---
Income statement
70 --165,874-
76A 08,6674,333-
9900 190,929172,47279,41830,303
60/61 --109,712-
62 --093
630 116,156118,01368,3235,890
640/8 5,4972,8492,523743
66A 10,190---
9901 59,08651,6108,57123,578
75/76B 38467381
75 38467381
65/66B 51,54947,12031,726192
65 51,54947,12031,726192
9903 7,9214,558-23,11623,387
67/77 5,9103,41908,304
9904 2,0111,139-23,11615,083
9905 2,0111,139-23,11615,083
Appropriation of the result
9906 -4,884-6,895-8,03415,083
14P -6,895-8,03415,083-
Document PDFPDFPDFPDF

The notes to these accounts have 15 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the accounts filed with the NBB.

Source: Annual accounts 2025 at the NBB, filed on 16-10-2026.

Download as CSV

Filings

each dot is a set of accounts, on the day it reached the National Bank

2025 annual accounts filed 77 days after the deadline. Filed on 16 October 2026, deadline 31 July 2026 (7 months after the close on 31 December 2025, Companies Code art. 3:10). Source: NBB, 2026-00560304.

Financial year Type Filed Reference Document
31-12-2025 micro format 16-10-2026 2026-00560304 PDF
31-12-2024 micro format 25-08-2025 2025-00397597 PDF
31-12-2023 micro format 09-10-2024 2024-00503524 PDF
31-12-2022 micro format 01-09-2023 2023-00408375 PDF

Key figures and ratios

per financial year, computed from the annual accounts
Line Trend2025202420232022
175,242169,62476,89529,468
118,168119,15245,20720,973
100,90592,8371.6m48,475
46,72313,97215,973-
-20,816-30,528-44,081-18,898
--5.2%-
0.5%-0.3%-0.4%39.4%
0.850.540.440.10
---1.54
26.4%--85.8%
0.1%0.1%-1.5%33.8%
3.403.602.42over 100
--39 days-
--53 days-

A ratio outside any meaningful range has been withheld (balance sheet total €1.6m, equity €7,616).

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Investments

fixed assets acquired
Item2025202420232022
Tangible fixed assets€25,905€92,837€1.4m€48,475
Intangible fixed assets--€144,240-
Financial fixed assets€75,000---
€116,156€118,013€68,323€5,890

Source: notes to the 2022 to 2025 annual accounts (statement of fixed assets)

Insights on Oncolo-Co

The operating result for 2025 is 14% higher than in 2024 and the highest since 2022. It is the second rise in a row, after the fall in 2023.

Debt's share of the balance-sheet total is 67.0%.

Next steps